PMID: 6396777Jan 1, 1984Paper

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
P P Carbone

Abstract

The acceptance of ACT has been very rapid since 1974 although earlier studies by Nissen-Meyer and the NSABP in the 1960's originally suggested the effectiveness of modest short-term chemotherapy [16, 17]. The current practice is to administer combination chemotherapy for at least 6 months in all node-positive women. The survival benefits are clearly established only for women who are premenopausal and who have fewer than three positive nodes. Trials in other groups of patients are highly suggestive but have lacked some or all of the rigorous standards of the randomized clinical trial. The reasons for this widespread acceptance of ACT are not clear, but both patients and physicians are able to appreciate the concepts and bear the costs in terms of money as well as toxicity. The risks of ACT are mainly short term and reversible. Long-term consequences are not so readily apparent as yet. The benefits of improved survival will only be appreciated as more time passes, either through the long-term analyses of the current trials or the overwhelming success of a new strategy. Then all the past arguments about one therapy or another will become irrelevant. At that point this new miracle treatment will be so good that none will ask wheth...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.